Immunohematology in COVID-19 Patients: A Hospital-based Retrospective Cohort Study

NCT04932954 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2021-06-21

No results posted yet for this study

Summary

This is a hospital-based retrospective cohort study and the Immunohematologic characteristics of COVID-19 patients will be investigated systematically.

Conditions

  • Covid19

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH
  • Henan University of Science and Technology

    collaborator OTHER
  • LI YAN

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-01
Primary Completion
2022-01-01
Completion
2023-01-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04932954 on ClinicalTrials.gov